HIFs enhance the transcriptional activation and splicing of adrenomedullin

Molecular Cancer Research

Volumn 12, Issue 5, 2014, Pages 728-741

  Sena, Johnny A ^a   Wang, Liyi ^a   Pawlus, Matthew R ^a   Hu, Cheng Jun ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; HYPOXIA INDUCIBLE FACTOR; MESSENGER RNA; PEPTIDE DERIVATIVE; PROADRENOMEDULLIN N TERMINAL 20 PEPTIDE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ANGIOGENESIS; ARTICLE; CANCER CELL; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPOXIA; INTRON; INTRON RETENTION; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION; RNA SPLICING; TRANSCRIPTION INITIATION; CELL HYPOXIA; GENE SILENCING; GENETIC TRANSFECTION; GENETICS; METABOLISM; UMBILICAL VEIN ENDOTHELIAL CELL;

ADRENOMEDULLIN; CELL HYPOXIA; GENE KNOCKDOWN TECHNIQUES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; RNA SPLICING; TRANSCRIPTIONAL ACTIVATION; TRANSFECTION;

EID: 84900436322     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-13-0607     Document Type: Article

References (43)

1. Finger EC, Giaccia AJ. Hypoxia, inflammation, and the tumor microenvironment in metastatic disease. Cancer Metastasis Rev 2010;29:285-93.
2. Kaelin WGJr. Cancer and altered metabolism: potential importance of hypoxia-inducible factor and 2-oxoglutarate-dependent dioxygenases. Cold Spring Harb Symp Quant Biol 2011;76:335-45.
3. Keith B, Johnson RS, Simon MC. HIF-1alpha and HIF2alpha: sibling rivalry in hypoxic tumour growth and progression. Nat Rev Cancer 2012;12:9-22.
4. Semenza GL. Hypoxia-inducible factors in physiology and medicine. Cell 2012;148:399-408.
5. Park SJ, Kim JG, Son TG, Yi JM, Kim ND, Yang K, et al. The histone demethylase JMJD1A regulates adrenomedullin-mediated cell proliferation in hepatocellular carcinoma under hypoxia. Biochem Biophys Res Commun 2013;434:722-7.
6. Ouafik L, Sauze S, Boudouresque F, Chinot O, Delfino C, Fina F, et al. Neutralization of adrenomedullin inhibits the growth of human glioblastoma cell lines in vitro and suppresses tumor xenograft growth in vivo. Am J Pathol 2002;160:1279-92.
7. Martinez A. Biology of adrenomedullin. Introduction. Microsc Res Tech 2002;57:1-2.
8. Kawakami Y. [Adrenomedullin antagonist suppresses in vivo proliferation of cancer cells in SCID mice via angiogenesis inhibition]. Hokkaido Igaku Zasshi 2005;80:575-83.
9. Tsuchiya K, Hida K, Hida Y, Muraki C, Ohga N, Akino T, et al. Adrenomedullin antagonist suppresses tumor formation in renal cell carcinoma through inhibitory effects on tumor endothelial cells and endothelial progenitor mobilization. Int J Oncol 2010;36:1379-86.
10. Deville JL, Bartoli C, Berenguer C, Fernandez-Sauze S, Kaafarani I, Delfino C, et al. Expression and role of adrenomedullin in renal tumors and value of its mRNA levels as prognostic factor in clear-cell renal carcinoma. Int J Cancer 2009;125:2307-15.
11. Oehler MK, Norbury C, Hague S, Rees MC, Bicknell R. Adrenomedullin inhibits hypoxic cell death by upregulation of Bcl-2 in endometrial cancer cells: a possible promotion mechanism for tumour growth. Oncogene 2001;20:2937-45.
12. Oehler MK, Hague S, Rees MC, Bicknell R. Adrenomedullin promotes formation of xenografted endometrial tumors by stimulation of autocrine growth and angiogenesis. Oncogene 2002;21:2815-21.
13. Nikitenko LL, MacKenzie IZ, Rees MC, Bicknell R. Adrenomedullin is an autocrine regulator of endothelial growth in human endometrium. Mol Hum Reprod 2000;6:811-9.
14. Eto T, Samson WK. Adrenomedullin and proadrenomedullin N-terminal 20 peptide: vasodilatory peptides with multiple cardiovascular and endocrine actions. Trends Endocrinol Metab 2001;12:91-3.
15. Nakamura M, Yoshida H, Hiramori K. Comparison of vasodilator potency of adrenomedulling and proadrenomedullin N-terminal 20 peptide in human. Life Sci 1999;65:2151-6.
16. Martinez A, Zudaire E, Portal-Nunez S, Guedez L, Libutti SK, Stetler-Stevenson WG, et al. Proadrenomedullin NH2-terminal 20 peptide is a potent angiogenic factor, and its inhibition results in reduction of tumor growth. Cancer Res 2004;64:6489-94.
17. Martinez A, Hodge DL, Garayoa M, Young HA, Cuttitta F. Alternative splicing of the proadrenomedullin gene results in differential expression of gene products. J Mol Endocrinol 2001;27:31-41.
18. Pawlus MR, Wang L, Ware K, Hu CJ. Upstream stimulatory factor 2 and hypoxia-inducible factor 2alpha (HIF2alpha) cooperatively activate HIF2 target genes during hypoxia. Mol Cell Biol 2012;32:4595-610.
19. Pawlus MR, Wang L, Murakami A, Dai G, Hu CJ. STAT3 or USF2 contributes to HIF target gene specificity. PloS ONE 2013;8:e72358.
20. Hu CJ, Sataur A, Wang L, Chen H, Simon MC. The N-terminal transactivation domain confers target gene specificity of hypoxiainducible factors HIF-1alpha and HIF-2alpha. Mol Biol Cell 2007;18: 4528-42.
21. Blau J, Xiao H, McCracken S, O'Hare P, Greenblatt J, Bentley D. Three functional classes of transcriptional activation domain. Mol Cell Biol 1996;16:2044-55.
22. Lejeune F, Maquat LE. Mechanistic links between nonsense-mediated mRNA decay and pre-mRNA splicing in mammalian cells. Curr Opin Cell Biol 2005;17:309-15.
23. Wong JJ, Ritchie W, Ebner OA, Selbach M, Wong JW, Huang Y, et al. Orchestrated intron retention regulates normal granulocyte differentiation. Cell 2013;154:583-95.
24. Kitamuro T, Takahashi K, Nakayama M, Murakami O, Hida W, Shirato K, et al. Induction of adrenomedullin during hypoxia in cultured human glioblastoma cells. J Neurochem 2000;75:1826-33.
25. Hu CJ, Wang LY, Chodosh LA, Keith B, Simon MC. Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Mol Cell Biol 2003;23:9361-74.
26. Auboeuf D, Dowhan DH, Kang YK, Larkin K, Lee JW, Berget SM, et al. Differential recruitment of nuclear receptor coactivators may determine alternative RNA splice site choice in target genes. Proc Natl Acad Sci U S A 2004;101:2270-4.
27. Auboeuf D, Dowhan DH, Li X, Larkin K, Ko L, Berget SM, et al. CoAA, a nuclear receptor coactivator protein at the interface of transcriptional coactivation and RNA splicing. Mol Cell Biol 2004;24:442-53.
28. Cheng D, Cote J, Shaaban S, Bedford MT. The arginine methyltransferase CARM1 regulates the coupling of transcription and mRNA processing. Mol Cell 2007;25:71-83.
29. Yang BC, Lippton H, Gumusel B, Hyman A, Mehta JL. Adrenomedullin dilates rat pulmonary artery rings during hypoxia: role of nitric oxide and vasodilator prostaglandins. J Cardiovasc Pharmacol 1996;28: 458-62.
30. LaCava J, Houseley J, Saveanu C, Petfalski E, Thompson E, Jacquier A, et al. RNA degradation by the exosome is promoted by a nuclear polyadenylation complex. Cell 2005;121:713-24.
31. Vanacova S, Wolf J, Martin G, Blank D, Dettwiler S, Friedlein A, et al. A new yeast poly(A) polymerase complex involved in RNA quality control. PLoS Biol 2005;3:e189.
32. Wyers F, Rougemaille M, Badis G, Rousselle JC, Dufour ME, Boulay J, et al. Cryptic pol II transcripts are degraded by a nuclear quality control pathway involving a new poly(A) polymerase. Cell 2005;121:725-37.
33. Rosonina E, Ip JY, Calarco JA, Bakowski MA, Emili A, McCracken S, et al. Role for PSF in mediating transcriptional activator-dependent stimulation of pre-mRNA processing in vivo. Mol Cell Biol 2005;25: 6734-46.
34. Nogues G, Kadener S, Cramer P, Bentley D, Kornblihtt AR. Transcriptional activators differ in their abilities to control alternative splicing. J Biol Chem 2002;277:43110-4.
35. Cramer P, Pesce CG, Baralle FE, Kornblihtt AR. Functional association between promoter structure and transcript alternative splicing. Proc Natl Acad Sci U S A 1997;94:11456-60.
36. Cramer P, Caceres JF, Cazalla D, Kadener S, Muro AF, Baralle FE, et al. Coupling of transcription with alternative splicing:RNApol II promoters modulate SF2/ASF and 9G8 effects on an exonic splicing enhancer. Mol cell 1999;4:251-8.
37. Auboeuf D, Honig A, Berget SM, O'Malley BW. Coordinate regulation of transcription and splicing by steroid receptor coregulators. Science 2002;298:416-9.
38. Kornblihtt AR. Coupling transcription and alternative splicing. Adv Exp Med Biol 2007;623:175-89.
39. Kornblihtt AR, de la Mata M, Fededa JP, Munoz MJ, Nogues G. Multiple links between transcription and splicing. RNA 2004;10: 1489-98.
40. Perales R, Bentley D. "Cotranscriptionality": the transcription elongation complex as a nexus for nuclear transactions. Mol Cell 2009;36: 178-91.
41. Sena JA, Wang L, Hu CJ. BRG1 and BRM chromatin-remodeling complexes regulate the hypoxia response by acting as coactivators for a subset of hypoxia-inducible transcription factor target genes. Mol Cell Biol 2013;33:3849-63.
42. Batsche E, Yaniv M, Muchardt C. The human SWI/SNF subunit Brm is a regulator of alternative splicing. Nat Struct Mol Biol 2006;13:22-9.
43. Braunschweig U, Gueroussov S, Plocik AM, Graveley BR, Blencowe BJ. Dynamic integration of splicing within gene regulatory pathways. Cell 2013;152:1252-69.